Tilray Inc - Asset Resilience Ratio
Tilray Inc (TLRY) has an Asset Resilience Ratio of 0.74% as of February 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Tilray Inc (TLRY) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Tilray Inc's Asset Resilience Ratio has changed over time. See TLRY net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Tilray Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tilray Inc market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$15.31 Million | 0.74% |
| Total Liquid Assets | CA$15.31 Million | 0.74% |
Asset Resilience Insights
- Limited Liquidity: Tilray Inc maintains only 0.74% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tilray Inc Industry Peers by Asset Resilience Ratio
Compare Tilray Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
SIMCERE PHARMAC. GRP LTD
F:S2P |
Drug Manufacturers - Specialty & Generic | 0.44% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
Annual Asset Resilience Ratio for Tilray Inc (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Tilray Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-05-31 | 1.67% | CA$34.70 Million ≈ $25.10 Million |
CA$2.07 Billion ≈ $1.50 Billion |
+0.91pp |
| 2024-05-31 | 0.76% | CA$32.18 Million ≈ $23.28 Million |
CA$4.22 Billion ≈ $3.05 Billion |
-4.85pp |
| 2023-05-31 | 5.62% | CA$241.90 Million ≈ $174.98 Million |
CA$4.31 Billion ≈ $3.12 Billion |
-- |
| 2022-05-31 | 0.00% | CA$0.00 ≈ $0.00 |
CA$5.45 Billion ≈ $3.94 Billion |
-- |
| 2020-05-31 | 0.00% | CA$0.00 ≈ $0.00 |
CA$1.80 Billion ≈ $1.30 Billion |
-- |
| 2019-05-31 | 0.83% | CA$14.93 Million ≈ $10.80 Million |
CA$1.80 Billion ≈ $1.31 Billion |
-2.60pp |
| 2018-05-31 | 3.43% | CA$34.95 Million ≈ $25.28 Million |
CA$1.02 Billion ≈ $737.20 Million |
-24.21pp |
| 2017-05-31 | 27.64% | CA$64.84 Million ≈ $46.90 Million |
CA$234.54 Million ≈ $169.66 Million |
-- |
About Tilray Inc
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more